Publication: Urinary neopterin in patients with systemic lupus erythematosus
Issued Date
1991-03-26
Resource Type
ISSN
00099147
Other identifier(s)
2-s2.0-0026083327
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Chemistry. Vol.37, No.1 (1991), 47-50
Suggested Citation
L. Leohirun, P. Thuvasethakul, V. Sumethkul, T. Pholcharoen, V. Boonpucknavig Urinary neopterin in patients with systemic lupus erythematosus. Clinical Chemistry. Vol.37, No.1 (1991), 47-50. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/21991
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Urinary neopterin in patients with systemic lupus erythematosus
Other Contributor(s)
Abstract
Concentrations of neopterin were measured in urine specimens from 35 patients with active and eight with inactive systemic lupus erythematosus (SLE). Compared with those of apparently healthy controls, neopterin concentrations were higher in patients with active disease (P < 0.001) and with inactive disease (P < 0.01), those in patients with active disease being significantly higher than those in patients with inactive disease (P < 0.001). The correlation between the neopterin concentration and evidence of disease activity was good. All of the patients with clinically active SLE had increased neopterin, but for only 37.5% (three of eight) did the neopterin concentration exceed the upper normal limit during clinical remission. The increase in neopterin concentration did not correlate with clinical courses or severity of renal function. Moreover, serial determinations of neopterin in active SLE patients showed a rapid decrease of initially high concentration, paralleling a decline of clinical activity after initiation of medical therapy. Thus, urinary neopterin may be a useful marker for monitoring disease activity in SLE patients.